搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
药品
/
snoa
/
财务摘要
Sonoma Pharmaceuticals Inc
SNOA
添加自选
1.280
USD
+0.020
+1.59%
收盘 09-18 16:00(美东)
6.17M
总市值
亏损
市盈率 TTM
Sonoma Pharmaceuticals Inc
1.280
+0.020
+1.59%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
SNOA 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Sonoma Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
6.17M
股息TTM
0.00
市盈率 TTM
-0.66
每股收益TTM
-1.94
营业收入
19.53M
净利润
-3.46M
净资产收益率
-81.19%
总资产收益率
-24.70%
Sonoma Pharmaceuticals Inc 财报日历
最新发布
8月 7, 2026
每股收益 / 预测值
-0.09
/-0.30
营业收入 / 预测值
6.41M
/4.99M
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2027Q1
FY2026Q4
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
财务指标
每股收益
88.65%
-0.09
30.39%
-0.33
24.57%
-0.48
45.01%
-0.32
43.66%
-0.76
65.45%
-0.48
60.07%
-0.63
89.74%
-0.59
76.64%
-1.34
77.30%
-1.39
87.28%
-1.59
--
-5.75
--
-5.75
--
-6.13
--
-12.48
--
-12.28
--
--
--
--
--
--
--
--
营业收入
59.55%
6.41M
48.14%
5.56M
22.03%
4.35M
56.58%
5.60M
18.40%
4.01M
9.16%
3.75M
13.58%
3.56M
31.05%
3.58M
-1.05%
3.39M
14.10%
3.44M
6.59%
3.14M
-18.01%
2.73M
-13.96%
3.43M
31.16%
3.01M
1.45%
2.94M
-11.03%
3.33M
8.12%
3.98M
6.54%
2.30M
-41.21%
2.90M
-35.10%
3.74M
净利润
73.41%
-330.00K
25.13%
-581.00K
11.75%
-819.00K
12.46%
-534.00K
-8.57%
-1.24M
27.27%
-776.00K
-7.16%
-928.00K
58.89%
-610.00K
19.39%
-1.14M
18.43%
-1.07M
55.34%
-866.00K
-45.92%
-1.48M
-59.86%
-1.42M
55.57%
-1.31M
-105.40%
-1.94M
-917.00%
-1.02M
19.22%
-887.00K
19.56%
-2.94M
-45.23%
-944.00K
-183.33%
-100.00K
利润率
83.33%
-5.15%
49.46%
-10.45%
27.68%
-18.83%
44.09%
-9.53%
8.30%
-30.91%
33.38%
-20.67%
5.65%
-26.04%
68.63%
-17.04%
18.54%
-33.71%
28.51%
-31.03%
58.10%
-27.60%
--
-54.34%
--
-41.38%
--
-43.40%
--
-65.86%
--
-26.03%
--
--
--
--
--
--
--
--
毛利率
10.32%
40.23%
-3.65%
39.22%
6.47%
37.94%
-0.52%
37.83%
-5.32%
36.46%
28.30%
40.70%
-23.41%
35.63%
4.90%
38.03%
9.62%
38.51%
9.15%
31.72%
62.68%
46.53%
--
36.25%
--
35.13%
--
29.06%
--
28.60%
--
40.95%
--
--
--
--
--
--
--
--
资产负债率
-18.82%
0.77%
-1.02%
1.59%
--
0.00%
-32.55%
0.40%
-36.16%
0.95%
-26.68%
1.61%
-100.00%
0.00%
-52.50%
0.60%
-21.22%
1.49%
-17.48%
2.19%
179.48%
0.30%
--
1.26%
--
1.89%
--
2.66%
--
0.11%
--
1.63%
--
--
--
--
--
--
--
--
利润表
营业收入
59.55%
6.41M
48.14%
5.56M
22.03%
4.35M
56.58%
5.60M
18.40%
4.01M
9.16%
3.75M
13.58%
3.56M
31.05%
3.58M
-1.05%
3.39M
14.10%
3.44M
6.59%
3.14M
-18.01%
2.73M
-13.96%
3.43M
31.16%
3.01M
1.45%
2.94M
-11.03%
3.33M
8.12%
3.98M
6.54%
2.30M
-41.21%
2.90M
-35.10%
3.74M
营业利润
96.35%
-40.00K
46.49%
-351.00K
34.24%
-678.00K
60.35%
-337.00K
6.65%
-1.09M
53.44%
-656.00K
-22.16%
-1.03M
29.64%
-850.00K
5.40%
-1.17M
-24.14%
-1.41M
53.70%
-844.00K
-64.35%
-1.21M
-94.36%
-1.24M
63.15%
-1.14M
-93.11%
-1.82M
24.23%
-735.00K
5.34%
-638.00K
-7.69%
-3.08M
-50.80%
-944.00K
-428.81%
-970.00K
净利润
73.41%
-330.00K
25.13%
-581.00K
11.75%
-819.00K
12.46%
-534.00K
-8.57%
-1.24M
27.27%
-776.00K
-7.16%
-928.00K
58.89%
-610.00K
19.39%
-1.14M
18.43%
-1.07M
55.34%
-866.00K
-45.92%
-1.48M
-59.86%
-1.42M
55.57%
-1.31M
-105.40%
-1.94M
-917.00%
-1.02M
19.22%
-887.00K
19.56%
-2.94M
-45.23%
-944.00K
-183.33%
-100.00K
资产负债表
流动资产
24.12%
16.27M
-4.33%
12.10M
-1.90%
12.14M
2.29%
12.50M
9.89%
13.11M
0.80%
12.65M
-0.98%
12.38M
6.12%
12.22M
-12.22%
11.93M
-9.06%
12.55M
11.31%
12.50M
-7.08%
11.52M
-8.30%
13.59M
-16.02%
13.80M
-36.54%
11.23M
-31.23%
12.39M
21.88%
14.82M
26.55%
16.43M
9.17%
17.70M
10.78%
18.02M
流动负债总额
12.36%
5.45M
17.97%
4.83M
13.88%
4.22M
30.61%
4.32M
29.25%
4.85M
10.14%
4.10M
20.46%
3.70M
2.16%
3.31M
-7.18%
3.75M
0.05%
3.72M
-21.86%
3.07M
-8.17%
3.24M
-16.75%
4.04M
-36.12%
3.72M
1.52%
3.93M
-13.51%
3.53M
-7.24%
4.85M
42.69%
5.82M
-0.21%
3.88M
-10.75%
4.08M
总资产
24.07%
18.11M
1.95%
13.96M
-0.33%
13.62M
1.25%
13.86M
6.74%
14.59M
-7.10%
13.69M
-6.50%
13.67M
0.37%
13.69M
-13.97%
13.67M
-9.19%
14.74M
4.95%
14.62M
-8.87%
13.63M
-7.37%
15.89M
-13.87%
16.23M
-28.01%
13.93M
-24.54%
14.96M
21.51%
17.16M
25.74%
18.84M
6.12%
19.35M
9.28%
19.83M
总负债
9.25%
11.51M
17.05%
10.87M
15.83%
10.19M
20.83%
10.07M
21.15%
10.54M
7.89%
9.28M
11.00%
8.80M
4.69%
8.33M
0.54%
8.70M
4.23%
8.60M
-5.29%
7.93M
0.24%
7.96M
-5.96%
8.65M
-18.66%
8.25M
2.34%
8.37M
-5.10%
7.94M
-3.17%
9.20M
5.44%
10.15M
38.26%
8.18M
27.12%
8.37M
总权益
62.57%
6.59M
-29.83%
3.10M
-29.53%
3.43M
-29.24%
3.79M
-18.47%
4.06M
-28.12%
4.41M
-27.23%
4.87M
-5.69%
5.35M
-31.30%
4.97M
-23.07%
6.14M
20.38%
6.69M
-19.17%
5.67M
-9.01%
7.24M
-8.28%
7.98M
-50.23%
5.56M
-38.73%
7.02M
72.24%
7.96M
62.17%
8.70M
-9.31%
11.17M
-0.88%
11.46M
现金流量表
经营净额
68.59%
-633.00K
-446.32%
-519.00K
-235.22%
-764.00K
-279.38%
-635.00K
-120.94%
-2.02M
-162.50%
-95.00K
151.18%
565.00K
128.76%
354.00K
-324.19%
-912.00K
106.23%
152.00K
-217.24%
-1.10M
32.73%
-1.23M
85.98%
-215.00K
-74.98%
-2.44M
-6.75%
-348.00K
-40.34%
-1.83M
-25.35%
-1.53M
5.49%
-1.40M
-143.70%
-326.00K
-265.27%
-1.30M
投资净额
98.11%
-2.00K
38.30%
-29.00K
-2250.00%
-47.00K
61.54%
-10.00K
-2020.00%
-106.00K
-361.11%
-47.00K
-100.00%
-2.00K
-1200.00%
-26.00K
70.59%
-5.00K
121.95%
18.00K
-102.94%
-1.00K
98.93%
-2.00K
26.09%
-17.00K
-34.43%
-82.00K
--
34.00K
-1800.00%
-187.00K
53.06%
-23.00K
-1425.00%
-61.00K
100.00%
0.00
113.92%
11.00K
融资净额
6055.17%
3.45M
59.92%
387.00K
-70.34%
210.00K
-104.29%
-62.00K
-109.12%
-58.00K
-61.09%
242.00K
-46.28%
708.00K
1219.38%
1.44M
571.11%
636.00K
-81.55%
622.00K
514.47%
1.32M
27.53%
-129.00K
65.12%
-135.00K
1418.92%
3.37M
-168.68%
-318.00K
-102.57%
-178.00K
-85.17%
-387.00K
-17.47%
222.00K
91.32%
463.00K
3148.83%
6.92M
营业收入
业务
报告期:
暂无数据
地区
报告期:
暂无数据
常见问题
Sonoma Pharmaceuticals Inc的总收入是多少?
根据Sonoma Pharmaceuticals Inc的FY2026财报,总收入达到了19.53M(同比变化14.29M)。
Sonoma Pharmaceuticals Inc的流动资产是多少?
根据Sonoma Pharmaceuticals Inc的FY2026财报,流动资产为12.10M(同比变化-4.33)。
Sonoma Pharmaceuticals Inc的总资产是多少?
根据Sonoma Pharmaceuticals Inc的FY2026财报,Sonoma Pharmaceuticals Inc的总资产为13.96M(同比变化1.95)。
Sonoma Pharmaceuticals Inc的总负债是多少?
根据Sonoma Pharmaceuticals Inc的FY2026财报,Sonoma Pharmaceuticals Inc的总负债为10.87M(同比变化17.05)。
Sonoma Pharmaceuticals Inc的总权益是多少?
根据Sonoma Pharmaceuticals Inc的FY2026财报,Sonoma Pharmaceuticals Inc的总权益为3.10M(同比变化-29.83)。
Sonoma Pharmaceuticals Inc的净营业收入是多少?
根据Sonoma Pharmaceuticals Inc的FY2026财报,Sonoma Pharmaceuticals Inc的净营业收入为-2.46M(同比变化33.67)。
Sonoma Pharmaceuticals Inc的净投资是多少?
根据Sonoma Pharmaceuticals Inc的FY2026财报,Sonoma Pharmaceuticals Inc的净投资为-192.00K(同比变化-140.00)。
Sonoma Pharmaceuticals Inc的净融资是多少?
根据Sonoma Pharmaceuticals Inc的FY2026财报,Sonoma Pharmaceuticals Inc的净融资为477.00K(同比变化-84.26)。
Sonoma Pharmaceuticals Inc的每股收益(EPS)是多少?
根据Sonoma Pharmaceuticals Inc的FY2026财报,每股收益(EPS)为-1.89(同比变化32.32)。
Sonoma Pharmaceuticals Inc的净利润是多少?
根据Sonoma Pharmaceuticals Inc的FY2026财报,净利润为-3.17M(同比变化8.16)。
Sonoma Pharmaceuticals Inc的净利润率是多少?
根据Sonoma Pharmaceuticals Inc的FY2026财报,净利润率为-16.26(同比变化32.81)。
Sonoma Pharmaceuticals Inc的毛利率是多少?
根据Sonoma Pharmaceuticals Inc的FY2026财报,毛利率为37.97(同比变化-0.73)。
Sonoma Pharmaceuticals Inc的债务与资产比率是多少?
根据Sonoma Pharmaceuticals Inc的FY2026财报,债务与资产比率为1.59(同比变化-1.02)。
Sonoma Pharmaceuticals Inc的股东权益回报率(ROE)是多少?
根据Sonoma Pharmaceuticals Inc的FY2026财报,股东权益回报率(ROE)为-84.60(同比变化-29.06)。
Sonoma Pharmaceuticals Inc的资产回报率(ROA)是多少?
根据Sonoma Pharmaceuticals Inc的FY2026财报,资产回报率(ROA)为-22.96(同比变化5.57)。
Sonoma Pharmaceuticals Inc的营业利润是多少?
根据Sonoma Pharmaceuticals Inc的FY2026财报,营业利润为-2.46M(同比变化33.67)。